MTM Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
MTM Financial Group's IBB Position: Q3 2026 in Review
MTM Financial Group held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 1,857 shares worth $391K. The position accounts for 0.16% of the portfolio, ranked #64.
MTM Financial Group first reported a position in IBB in Q1 2022 and has held it in 19 quarters since. The position peaked at $448K in Q1 2022. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- MTM Financial Group held 1,857 shares of iShares Biotechnology ETF worth $391K as of Q3 2026.
- MTM Financial Group left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up 0.16% of MTM Financial Group's portfolio in Q3 2026, its #64 holding.
- MTM Financial Group first reported a position in iShares Biotechnology ETF in Q1 2022 and has held it in 19 quarters since.
- MTM Financial Group's iShares Biotechnology ETF position peaked at $448K in Q1 2022.
- 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on MTM Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.